Last updated at 23 hours ago
Director
DIN: 08659457
Eknath Pandurang Bhad is currently associated with 2 companies in various capacities such as Nominee, Individual Promoter and Director. They serve as a Director at MEB PHARMA CONSULTANCY (OPC) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08659457.Eknath Pandurang Bhad is currently involved in 3 different roles. Their most recent position is with MEB PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Eknath Pandurang Bhad was appointed to as a director was MEB PHARMA CONSULTANCY (OPC) PRIVATE LIMITED. Eknath Pandurang Bhad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Eknath Pandurang Bhad is currently associated with 2 companies in various capacities such as Nominee, Individual Promoter and Director. They serve as a Director at MEB PHARMA CONSULTANCY (OPC) PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08659457.Eknath Pandurang Bhad is currently involved in 3 different roles. Their most recent position is with MEB PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Eknath Pandurang Bhad was appointed to as a director was MEB PHARMA CONSULTANCY (OPC) PRIVATE LIMITED. Eknath Pandurang Bhad is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 1m 7 Months Interval
Company Name | Designation | Date of Appointment |
---|---|---|
MEB PHARMA CONSULTANCY (OPC) PRIVATE LIMITED | Nominee | 06-Sep-2019 |
MEB PHARMA PRIVATE LIMITED | Individual Promoter | 06-Jan-2020 |
MEB PHARMA PRIVATE LIMITED | Director | 06-Jan-2020 |